Erik Thomas - Profile and Investment Details

Investor Profile

Erik Thomas is a Private Equity Firm. based in Seattle, Washington, United States. with a diverse investment portfolio that includes companies such as Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics, Zavante Therapeutics, Calistoga Pharmaceuticals, Chimerix, Alnara Pharmaceuticals, Nuon Therapeutics, Stemgent, Moximed, Incline Therapeutics, VentiRx Pharmaceuticals, Calibra Medical, Mirum Pharmaceuticals, Intradigm Corporation, Tarsus Pharmaceuticals, Alpine Immune Sciences, Aptinyx, Alcresta, Barosense, Silvergate Pharmaceuticals, Dascena, Cirius Therapeutics, Outpost Medicine, Rempex Pharmaceuticals, Aspen Neuroscience, Collegium Pharmaceutical, Seraxis, Calibrium, Mavupharma, Inipharm, Sierra Oncology, PatientKeeper, Kalidex Pharmaceuticals, AcertaPharma, Merganser Biotech, AnaptysBio, Sojournix, Iovance Biotherapeutics, Portola Pharmaceuticals, EBR Systems, Imago BioSciences, MBX Biosciences, Vaxcyte, Primaeva Medical, Millendo Therapeutics, Clovis Oncology, Achaogen, Scout Bio, Cadence Pharmaceuticals, Passage Bio, Recida Therapeutics, Amunix, Phathom Pharmaceuticals, Lengo Therapeutics, Tobira Therapeutics, PowerVision, Calypso Medical, Cidara Therapeutics, Semnur Pharmaceuticals, CVRx, Gritstone Oncology, Glaukos, PreCision Dermatology, Threshold Pharmaceuticals, Iterum Therapeutics, Alteon Health, Arcutis Biotherapeutics, Entasis Therapeutics, Allena Pharmaceuticals, Laguna Pharmaceuticals.. Over time, Erik Thomas has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Erik Thomas is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Women Led, Life Science, Biotech, Medical Device, Healthcare, Biotechnology, Medical, Therapeutics, Machine Learning, Developer Platform, Pharmaceuticals. may find it worthwhile to explore potential connections with Erik Thomas, as their portfolio suggests a familiarity and interest in this area.

Understanding Erik Thomas’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.